Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0000950170-24-069309

Options or other derivatives

  • Chief Business & Legal Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Nickson Philip Chief Business & Legal Officer 2024-06-03 Grant or award · Stock Option (Right to Buy) +40,000 40,000 D
Loading xslF345X05/ownership.xml…